These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 34369245)
21. Rate of Adverse Events and Associated Health Care Costs for the Management of Inflammatory Bowel Disease in Germany. Wilke T; Groth A; Long GH; Tatro AR; Sun D Clin Ther; 2020 Jan; 42(1):130-143.e3. PubMed ID: 31883702 [TBL] [Abstract][Full Text] [Related]
22. [Therapy progression in surgery of inflammatory bowel diseases]. Zuo S; Wang X; Liu YC; Wang PY Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Aug; 15(8):872-6. PubMed ID: 22941697 [TBL] [Abstract][Full Text] [Related]
24. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort. Burisch J Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595 [TBL] [Abstract][Full Text] [Related]
25. No increased risk of nephrotoxicity associated with 5-aminosalicylic acid in IBD: a population-based cohort and nested case-control study. Jairath V; Hokkanen SRK; Guizzetti L; Boxall N; Campbell-Hill S; Patel H Aliment Pharmacol Ther; 2019 Aug; 50(4):416-424. PubMed ID: 31298421 [TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of tacrolimus in refractory ulcerative colitis and Crohn's disease: a single-center experience. Benson A; Barrett T; Sparberg M; Buchman AL Inflamm Bowel Dis; 2008 Jan; 14(1):7-12. PubMed ID: 17879277 [TBL] [Abstract][Full Text] [Related]
29. De novo Crohn's Disease after Ileal Pouch-Anal Anastomosis for Ulcerative Colitis and Inflammatory Bowel Disease Unclassified: Long-Term Follow-Up of a Prospective Inflammatory Bowel Disease Registry. Zaghiyan K; Kamiński JP; Barmparas G; Fleshner P Am Surg; 2016 Oct; 82(10):977-981. PubMed ID: 27779987 [TBL] [Abstract][Full Text] [Related]
30. Visceral adiposity and inflammatory bowel disease. Rowan CR; McManus J; Boland K; O'Toole A Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989 [TBL] [Abstract][Full Text] [Related]
31. Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG). Eriksson C; Marsal J; Bergemalm D; Vigren L; Björk J; Eberhardson M; Karling P; Söderman C; ; Myrelid P; Cao Y; Sjöberg D; Thörn M; Karlén P; Hertervig E; Strid H; Ludvigsson JF; Almer S; Halfvarson J Scand J Gastroenterol; 2017; 52(6-7):722-729. PubMed ID: 28362144 [TBL] [Abstract][Full Text] [Related]
32. Increased use of biologics in the era of TNF-α inhibitors did not reduce surgical rate but prolonged the time from diagnosis to first time intestinal resection among patients with Crohn's disease and ulcerative colitis - a Danish register-based study from 2003-2016. Qvist N; Vadstrup K; Alulis S; Borsi A; Munkholm P; Olsen J Scand J Gastroenterol; 2021 May; 56(5):537-544. PubMed ID: 33736551 [TBL] [Abstract][Full Text] [Related]
35. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis. Szamosi T; Banai J; Lakatos L; Czegledi Z; David G; Zsigmond F; Pandur T; Erdelyi Z; Gemela O; Papp M; Papp J; Lakatos PL Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):872-9. PubMed ID: 19648821 [TBL] [Abstract][Full Text] [Related]
36. Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis. Colombel JF; Sandborn WJ; Reinisch W; Peyrin-Biroulet L; Panaccione R; Rutgeerts P; Hanauer SB; Ghosh S; Van Assche G; Robinson AM; Lau W; Maa JF; Huang B; Pappalardo B; Read H Aliment Pharmacol Ther; 2018 Jan; 47(2):219-228. PubMed ID: 29159817 [TBL] [Abstract][Full Text] [Related]
37. Maintenance of remission with infliximab in inflammatory bowel disease: efficacy and safety long-term follow-up. Caviglia R; Ribolsi M; Rizzi M; Emerenziani S; Annunziata M; Cicala M World J Gastroenterol; 2007 Oct; 13(39):5238-44. PubMed ID: 17876895 [TBL] [Abstract][Full Text] [Related]
38. Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era-Results from the Dutch Population-Based IBDSL Cohort. Jeuring SFG; Biemans VBC; van den Heuvel TRA; Zeegers MP; Hameeteman WH; Romberg-Camps MJL; Oostenbrug LE; Masclee AAM; Jonkers DMAE; Pierik MJ Am J Gastroenterol; 2018 Mar; 113(3):384-395. PubMed ID: 29317770 [TBL] [Abstract][Full Text] [Related]
39. Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study. Pugliese D; Privitera G; Crispino F; Mezzina N; Castiglione F; Fiorino G; Laterza L; Viola A; Bertani L; Caprioli F; Cappello M; Barberio B; Ricci C; Balestrieri P; Daperno M; Pluchino D; Rizzello F; Scribano ML; Sablich R; Pastorelli L; Manguso F; Variola A; Di Sario A; Grossi L; Armuzzi A; Aliment Pharmacol Ther; 2022 Jul; 56(1):95-109. PubMed ID: 35876062 [TBL] [Abstract][Full Text] [Related]